FMT

FMT is an evolving therapy. There are several considerations for its use in UC but its use and role should be directed by further clinical trials.

Younger age, disease extent E2, and endoscopic mayo score 2 significantly predict achievement of clinical remission with FMT in active UC. The prediction model can help in selecting individuals for FMT. Validation in larger cohorts is needed.

Quadram Institute microbiologists have collaborated with clinicians at the Norfolk and Norwich University Hospital (NNUH) to develop and implement a successful new…

Maintenance FMT in patients who are in clinical remission may help sustain clinical, endoscopic and histological remission in patients with UC.

The Food and Drug Administration has approved a live fecal microbiota product (Rebyota) to prevent recurrence of Clostridioides difficile in adults.The product is approved for use following antibiotic treatment for recurrent episodes of C. difficile.

Practical use of fecal microbiota spores, live-brpk (formerly SER-109): an oral therapeutic for the prevention of recurrent Clostridioides difficile infection

Clostridioides difficile bacteria can cause excessive diarrhoea in patients, leading to further complications, such as severe dehydration and sepsis. Although C.difficile bacteria tend to reside harmlessly in many people's bowels, prolonged antibiotic use can alter the bacterial balanc …

Researchers wondered if a fecal transplant from a patient who had responded well to immunotherapy might improve the cure rate of those who did not.

The UK is conducting a large-scale trial into the use of faecal transplants to treat liver disease after a successful pilot of the “crapsules” suggested they mi

A pill filled with poo dubbed a 'crapsule' to boost gut health and prevent serious infections is starting a major trial of 300 people in 16 centres across the UK.

These findings suggested that imbalanced Th17/Treg cells decreased chicken growth performance, while FMT-reshaped gut microbiota, i.e., higher Lactobacilli, increased chicken growth performance by balancing Th17/Treg cells. Video Abstract.

“More #news: I am #proud to say we have established our #FMT bank @TheDickVet. Well screened donors, FMTs ready to go! Available for both #dogs and #cats! #InternalMedicine #gastroenterology #microbiome #guthealth #onwardsandupwards #cuttingedge #bestcare #innovationinhealthcare”

FMT treats immune-mediated colitis in patients by altering baseline microbial diversity and composition.

Fecal Microbiota Transplantation (FMT) Market is expected to reach US$ 1.75 Bn. at a CAGR of 4.9% during the forecast period 2029.

Keeping the community of microorganisms (including bacteria, fungi and viruses) that live in the digestive tract balanced helps keep us healthy, while an imbalance can cause illness.

Diabetes is one of the major applications of live biotherapeutic products and microbiome CDMO market and captured more than 35% share in the market during...

Our group has provided specific statements and recommendations, based on best available evidence, with the end goal of providing guidance and general criteria required to promote FMT as a recognised strategy for the treatment of IBD.

Across five clinical trials, RBL was well tolerated in adults with rCDI. In aggregate, these data consistently demonstrated the safety of RBL.

AbstractBackground. Individuals with a history of depression/depressive symptoms are suspected to be at increased risk of incident inflammatory bowel diseases (

A progressive degradation of the brain's structure and function, which results in a reduction in cognitive and motor skills, characterizes neurodegenerative diseases (NDs) such as Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD). …

Global Microbiome Therapeutics Market studied by MarketandResearch.biz focuses on thoughtful insight

Human gut microbiota are critical to both the development of and recovery from Clostridioides difficile infection (CDI). Antibiotics are the mainstay of CDI treatment, yet inherently cause further imbalances in the gut microbiota, termed dysbiosis, complicating recovery. A variety of microbio …

In conclusion, this study raises important questions about the interconnection of the gut microbiome and sleep disturbances.

Background and Aims: Fecal microbiota transplantation (FMT) has been increasingly studied in the inflammatory bowel disease (IBD) population. However, most studies have focused on the adult population, and the safety and efficacy of FMT in a pediatric population is less well understood. This …

Individuals with nonalcoholic fatty liver disease (NAFLD) have an altered gut microbiota composition. Moreover, hepatic DNA methylation may be altered in the state of NAFLD. Using a fecal microbiota transplantation (FMT) intervention, we aimed to investigate whether a change in gut microbiota compos …

FMT treats immune-mediated colitis in patients by altering baseline microbial diversity and composition.

Researchers provide an overview of fecal microbiota transplantation in treating recurrent Clostridioides difficile infection.

Immune checkpoint inhibitors (ICIs) target advanced malignancies with high efficacy but also predispose patients to immune-related adverse events like immune-mediated colitis (IMC). Given the association between gut bacteria with response to ICI therapy and subsequent IMC, fecal microbiota transplan …